NF1

Clinical trials for NF1 explained in plain language.

Never miss a new study

Get alerted when new NF1 trials appear

Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2

New hope for Tough-to-Treat sarcomas: Triple-Drug attack enters testing

Disease control Not yet recruiting

This study is testing a new combination of three drugs (selumetinib, ZEN-3694, and durvalumab) for people with advanced sarcomas that have not responded to standard treatments. The first part of the trial will find safe doses, and the second part will focus on a specific, aggress…

Matched conditions: NF1

Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control

Last updated Mar 06, 2026 15:38 UTC

NF1

Get alerted when new NF1 trials appear

New hope for Tough-to-Treat sarcomas: Triple-Drug attack enters testing